The Binaytara Foundation (BTF) is set to host its prestigious Annual Summit on Hematologic Cancers from October 11th, 2024, in Nashville, Tennessee, gathering some of the most prominent names in the field of blood cancer research. The three-day event will provide a dynamic platform for healthcare professionals, researchers, and industry leaders to exchange insights on the latest advancements in the diagnosis and treatment of hematologic malignancies such as leukemia, lymphoma, and multiple myeloma.

Designed to enhance learners’ understanding and skills by incorporating groundbreaking clinical data and expert insights to improve treatment outcomes for patients with blood cancers, the CME-accredited event will feature comprehensive discussions on recent scientific breakthroughs and transformative advancements, supported by case studies specific to hematologic malignancies.

Expert-led sessions will focus on the clinical application of various therapeutic options and explore how these treatments can be optimally integrated into patient care to maximize effectiveness.

In addition to featuring in-depth discussions on cutting-edge research and transformative therapies, one of the key highlights of the summit will be the Young Hematology Scholar Award. This recognition, aimed at encouraging early-career professionals, will be awarded to fellows and junior faculty members who have demonstrated remarkable contributions to the field within five years of their initial faculty appointment.

This year’s recipients are a distinguished group of emerging scholars, whose innovative research promises to shape the future of hematology:

1) Dr. Daniel Rosas, Hematology/Oncology Fellow at Memorial Cancer Institute, Florida.

2) Dr. Akriti Chaudhry, Oncology Fellow at the University of Illinois, Peoria.

3) Dr. Ayo Falade, Fellow at the Mayo Clinic and recipient of the SCHD Early Career Advancement Award.

4) Dr. Fahmin Basher, Fellow at Duke University.

5) Dr. Paolo Lopedote, Fellow at City of Hope.

6) Dr. Shinto Francis Thekkudan, Consultant and Chief of Clinical Hematology and Hemato Oncology at Baby Memorial Hospital in Kerala, India.

7) Andrew Pierce, MD, Internal Medicine Resident, PGY-2 – interested in Hematology/Oncology, learning under Daniel Ermann at University of Utah Health.

8) Neha Akkad, MD, Hematology/Oncology Fellow at MD Anderson.

9) Hannah Goulart, MD, Hematology/Oncology Fellow at University of Texas MD Anderson Cancer Center.

10) Karan Chohan, MD, Hematology/Oncology Fellow at University of Texas MD Anderson Cancer Center.

11) Himachandana Atluri, MD, Assistant Professor of Hematology/Oncology at Northwestern University.

By recognizing these young talents, the Binaytara Foundation underscores its commitment to fostering the next generation of leaders in hematology research, encouraging fresh ideas that could ultimately lead to groundbreaking treatments and improved patient outcomes.

As a premier provider of continuing medical education (CME/CE) for healthcare professionals in hematology and oncology, the Binaytara Foundation’s annual summit will bring together over 100 attendees, offering an unparalleled platform to engage with thought leaders in the field. The conference will not only serve as a hub for cutting-edge knowledge but also provide a unique networking opportunity to connect with top-tier physicians, nurses, pharmacists, and other professionals seeking to elevate their expertise and contribute to the future of hematology and oncology.

EVENT DETAILS:

2024 Summit on Hematological Cancers
Date: 11th-13th October, 2024
Location: Hutton Hotel, Nashville, Tennessee

* Click this link for more information.